Center Laboratories, Inc. (TPEX:4123)
41.40
-0.25 (-0.60%)
Mar 26, 2026, 1:30 PM CST
Center Laboratories Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 237.56 | 1,442 | 1,705 | 796.74 | 267.46 |
Short-Term Investments | 61.43 | 350.01 | 745.52 | 522.07 | - |
Trading Asset Securities | 363.83 | 258 | 973.87 | 1,029 | 4,582 |
Cash & Short-Term Investments | 662.82 | 2,050 | 3,424 | 2,348 | 4,849 |
Cash Growth | -67.67% | -40.12% | 45.83% | -51.58% | 319.43% |
Accounts Receivable | 234.29 | 202.69 | 244.61 | 174.35 | 114.78 |
Other Receivables | - | - | - | 14.52 | 457.93 |
Receivables | 234.29 | 202.69 | 244.61 | 188.87 | 572.71 |
Inventory | 353.48 | 309.7 | 269.23 | 89.31 | 100.64 |
Other Current Assets | 339.48 | 1,219 | 1,184 | 225.25 | 5,371 |
Total Current Assets | 1,590 | 3,782 | 5,121 | 2,851 | 10,893 |
Property, Plant & Equipment | 1,848 | 1,433 | 1,371 | 532.8 | 743.04 |
Long-Term Investments | 30,073 | 13,838 | 15,147 | 14,387 | 11,578 |
Goodwill | - | 398.36 | 398.36 | 1.35 | - |
Other Intangible Assets | 732.59 | 381.99 | 427.48 | 1.94 | 3.13 |
Long-Term Deferred Tax Assets | 17.61 | 32.51 | 11.22 | - | - |
Other Long-Term Assets | 366.89 | 5,672 | 4,526 | 7,413 | 7,227 |
Total Assets | 34,628 | 25,537 | 27,002 | 25,188 | 30,444 |
Accounts Payable | 119.32 | 134.79 | 144.64 | 100.56 | 30.31 |
Accrued Expenses | - | 142.28 | 139.89 | 440.36 | 89.15 |
Short-Term Debt | 1,050 | 1,262 | 330 | 310 | 1,252 |
Current Portion of Long-Term Debt | 1,892 | 2,596 | 852.89 | 1,869 | 433.33 |
Current Portion of Leases | 8.57 | 9.21 | 9.44 | 0.35 | 0.54 |
Current Income Taxes Payable | 81.24 | 277.33 | 211.34 | 953.24 | 267.15 |
Current Unearned Revenue | 169.02 | 159.25 | 113.67 | 84.07 | 113.51 |
Other Current Liabilities | 189.47 | 36.08 | 43.21 | 165.91 | 494.59 |
Total Current Liabilities | 3,510 | 4,617 | 1,845 | 3,923 | 2,680 |
Long-Term Debt | 1,774 | 2,655 | 4,412 | 1,289 | 3,676 |
Long-Term Leases | - | 8.17 | 17.13 | - | 0.09 |
Long-Term Unearned Revenue | - | 4.84 | - | - | - |
Long-Term Deferred Tax Liabilities | 2,408 | 148.74 | 434.02 | 717.74 | 2,113 |
Other Long-Term Liabilities | 449.79 | 49.26 | 77.81 | 5.3 | 879.67 |
Total Liabilities | 8,141 | 7,483 | 6,786 | 5,935 | 9,349 |
Common Stock | 7,612 | 7,250 | 6,914 | 5,948 | 5,050 |
Additional Paid-In Capital | 5,036 | 5,536 | 7,242 | 5,553 | 4,556 |
Retained Earnings | 14,337 | 5,460 | 5,823 | 7,754 | 9,680 |
Treasury Stock | -592.73 | -209.65 | -246.72 | - | - |
Comprehensive Income & Other | 93.76 | 18.86 | 24.42 | -2.14 | -347.79 |
Total Common Equity | 26,487 | 18,054 | 19,757 | 19,252 | 18,939 |
Minority Interest | 0.01 | 0.01 | 459.35 | - | 2,156 |
Shareholders' Equity | 26,487 | 18,054 | 20,216 | 19,252 | 21,095 |
Total Liabilities & Equity | 34,628 | 25,537 | 27,002 | 25,188 | 30,444 |
Total Debt | 4,725 | 6,530 | 5,621 | 3,468 | 5,362 |
Net Cash (Debt) | -4,062 | -4,480 | -2,197 | -1,120 | -512.52 |
Net Cash Per Share | -4.98 | -6.01 | -3.15 | -1.65 | -0.73 |
Filing Date Shares Outstanding | 752.41 | 756.94 | 720.84 | 686.88 | 668.41 |
Total Common Shares Outstanding | 752.41 | 756.94 | 720.84 | 686.88 | 668.41 |
Working Capital | -1,920 | -835.26 | 3,276 | -1,072 | 8,213 |
Book Value Per Share | 35.20 | 23.85 | 27.41 | 28.03 | 28.33 |
Tangible Book Value | 25,754 | 17,274 | 18,931 | 19,249 | 18,936 |
Tangible Book Value Per Share | 34.23 | 22.82 | 26.26 | 28.02 | 28.33 |
Land | - | 1,017 | 997.95 | 591.88 | 782.99 |
Machinery | - | 970.49 | 872.53 | 272.06 | 264.47 |
Construction In Progress | - | 76.77 | 46.26 | - | 2.78 |
Leasehold Improvements | - | 137.86 | 129.66 | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.